CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring

Analysts expect iRhythm to shift more of its long-term remote cardiac monitoring operations to its California facility to take advantage of new Medicare reimbursement rates set by the US Centers for Medicare and Medicaid Services.

Zio XT Patch Side View
iRhythm's Zio XT Patch • Source: iRhythm

After years of lobbying and data collection by industry and cardiology professional groups, the US Centers for Medicare and Medicaid Services has proposed to set national Medicare reimbursement rates for long-term cardiac monitoring, rather than rely on the rates set by the Medicare Administrative Contractors (MACs).

On 7 July, CMS announced a new Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023. The proposal...

More from Policy & Regulation

More from Medtech Insight

Endo Tools, Fujifilm Partner to Fast-Track Endomina Rollout Across MEA Region

 
• By 

CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By 

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.